AI assistant
Sending…
PETMED EXPRESS INC — Director's Dealing 2021
Jan 28, 2021
34556_dirs_2021-01-28_24f194b1-fe6c-48c4-8128-7e13efc69ed5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PETMED EXPRESS INC (PETS)
CIK: 0001040130
Period of Report: 2021-01-27
Reporting Person: AKDAG MENDERES (Director, CEO & President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-01-27 | COMMON STOCK | S | 60000 | $45.50 | Disposed | 337800 | Direct |
Footnotes
F1: The reported transactions are pursuant to a pre-arranged structured sales plan that is in accordance with both the Securities and Exchange Commission's Rule 10b5-1 and the PetMed Express, Inc. insider trading policy.
More from PETMED EXPRESS INC
Annual Report
2026
Jun 2
Report Publication Announcement
2026
Jun 2
Regulatory Filings
2026
May 21
Major Shareholding Notification
2026
Feb 11
Interim / Quarterly Report
2026
Feb 5
Declaration of Voting Results & Voting Rights Announcements
2026
Jan 23
Director's Dealing
2026
Jan 23
Interim / Quarterly Report
2025
Dec 19
Interim / Quarterly Report
2025
Dec 19
Major Shareholding Notification
2025
Dec 11